175 related articles for article (PubMed ID: 22233101)
1. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
Win N; Lee E; Needs M; Chia LW; Stasi R
Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
[TBL] [Abstract][Full Text] [Related]
2. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
Reyes MA; Illoh OC
Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130
[TBL] [Abstract][Full Text] [Related]
3. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
Win N; Sinha S; Lee E; Mills W
Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
[TBL] [Abstract][Full Text] [Related]
4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
5. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
Lee LE; Beeler BW; Graham BC; Cap AP; Win N; Chen F
Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065
[TBL] [Abstract][Full Text] [Related]
6. Hyperhemolytic transfusion reaction in sickle cell disease.
Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
[TBL] [Abstract][Full Text] [Related]
7. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.
Cullis JO; Win N; Dudley JM; Kaye T
Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307
[TBL] [Abstract][Full Text] [Related]
8. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
Win N; New H; Lee E; de la Fuente J
Transfusion; 2008 Jun; 48(6):1231-8. PubMed ID: 18373500
[TBL] [Abstract][Full Text] [Related]
9. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
10. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
Dean CL; Maier CL; Roback JD; Stowell SR
Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin concentration in sickle cell crisis.
Brownell A; Lowson S; Brozović M
J Clin Pathol; 1986 Mar; 39(3):253-5. PubMed ID: 3958215
[TBL] [Abstract][Full Text] [Related]
12. Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.
Madu AJ; Ugwu AO; Efobi C
Med Princ Pract; 2021; 30(3):236-243. PubMed ID: 33176303
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
Uhlmann EJ; Shenoy S; Goodnough LT
Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
15. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
[TBL] [Abstract][Full Text] [Related]
16. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
[TBL] [Abstract][Full Text] [Related]
18. Case reports: delayed hemolytic transfusion reaction in sickle cell disease.
Syed SK; Sears DA; Werch JB; Udden MM; Milam JD
Am J Med Sci; 1996 Oct; 312(4):175-81. PubMed ID: 8853066
[TBL] [Abstract][Full Text] [Related]
19. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
Thonier V
Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
[TBL] [Abstract][Full Text] [Related]
20. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
